<DOC>
	<DOC>NCT00529659</DOC>
	<brief_summary>A study to evaluate the safety, tolerability, and efficacy of MK-0773 in women with sarcopenia (loss of muscle mass).</brief_summary>
	<brief_title>A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005)</brief_title>
	<detailed_description />
	<mesh_term>Sarcopenia</mesh_term>
	<criteria>Patient is a woman who is 65 years of age or older Patient's lean body mass is at least 1 standard deviation below the mean of a healthy young adult population Patient has difficulty climbing 10 steps or walking outside on level ground for 1/4 mile without resting or Activity Measure for Post Acute Care (AMPAC)&lt;66 Patient has serious neurological, rheumatologic, cardiac, respiratory, kidney, psychiatric conditions Patient has a history of certain types of cancer</criteria>
	<gender>Female</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Sarcopenia (loss of muscle mass)</keyword>
</DOC>